FEBU

Fellow of the European Board of Urology

Metastatic Prostate CancerEnglish
Exam overview

Practice session

A 64-year-old man presents with de novo metastatic hormone-sensitive prostate cancer with multiple bone metastases, good performance status and no major contraindication to systemic therapy. Which principle should guide first-line treatment?

Loading your practice session…